1606 Corp. Files 8-K for Disclosure and Exhibits
Ticker: CBDW · Form: 8-K · Filed: Dec 18, 2024 · CIK: 1877461
Sentiment: neutral
Topics: disclosure, financials, filing
TL;DR
1606 CORP. filed an 8-K on 12/18/24 for disclosures and exhibits.
AI Summary
On December 18, 2024, 1606 Corp. filed a Form 8-K to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's status as a Nevada corporation with its principal executive offices located in Phoenix, Arizona.
Why It Matters
This filing provides important updates and disclosures for 1606 Corp. investors and stakeholders regarding the company's financial status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain any immediately concerning information.
Key Players & Entities
- 1606 Corp. (company) — Registrant
- December 18, 2024 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- Phoenix, AZ (location) — Principal Executive Offices
- 602-481-1544 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for 1606 Corp.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and Financial Statements and Exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on December 18, 2024.
In which state is 1606 Corp. incorporated?
1606 Corp. is incorporated in Nevada.
What is the address of 1606 Corp.'s principal executive offices?
The address of 1606 Corp.'s principal executive offices is 2425 E. Camelback Rd Suite 150, Phoenix, AZ 85016.
What is the Commission File Number for 1606 Corp.?
The Commission File Number for 1606 Corp. is 000-56467.
Filing Stats: 646 words · 3 min read · ~2 pages · Grade level 10.7 · Accepted 2024-12-18 08:14:05
Filing Documents
- onesix_8k.htm (8-K) — 26KB
- onesix_ex991.htm (EX-99.1) — 16KB
- 0001477932-24-008169.txt ( ) — 162KB
- cbdw-20241218.xsd (EX-101.SCH) — 6KB
- cbdw-20241218_lab.xml (EX-101.LAB) — 13KB
- cbdw-20241218_cal.xml (EX-101.CAL) — 1KB
- cbdw-20241218_pre.xml (EX-101.PRE) — 8KB
- cbdw-20241218_def.xml (EX-101.DEF) — 2KB
- onesix_8k_htm.xml (XML) — 4KB
01
Item 7.01 Regulation FD Disclosure. On December 18, 2024, 1606 Corp., a Nevada corporation (the "Company"), filed a press release which issued a statement in support of Adnexus Biotechnologies Inc., following the company's recent announcement of its revolutionary Neural Temporal Fingerprinting technology for personalized health monitoring. The furnishing of the press release is not an admission as to the materiality of any information therein. The information contained in the press release is summary information that is intended to be considered in the context of more complete information included in the Company's filings with the U.S. Securities and Exchange Commission (the " SEC ") and other public announcements that the Company has made and may make from time to time by press release or otherwise. The Company undertakes no duty or obligation to update or revise the information contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures. The information in this Item 7.01 of this Current Report on Form 8-K and the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the press release shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated December 18, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 1606 Corp. Date: December 18, 2024 By: /s/ Austen Lambrecht Austen Lambrecht, Chief Executive Officer 3